Cited by

• CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats.

  Mason B, Calhoun C, Woytowicz V, Pina L, Kanda R, Dunn C, Alves A, Donaldson ST. Mason B, et al. PLoS One. 2021 Mar 1;16(3):e0247707. doi: 10.1371/journal.pone.0247707. eCollection 2021. PLoS One. 2021. PMID: 33647040 Free PMC article.
• The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.

  Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, de-la-Forest Divonne S, Paquis P, Preynat-Seauve O, Krause KH, Chneiweiss H, Virolle T. Fareh M, et al. Cell Death Differ. 2012 Feb;19(2):232-44. doi: 10.1038/cdd.2011.89. Epub 2011 Jul 1. Cell Death Differ. 2012. PMID: 21720384 Free PMC article.
• Non-coding RNAs and glioma: Focus on cancer stem cells.

  Rajabi A, Kayedi M, Rahimi S, Dashti F, Mirazimi SMA, Homayoonfal M, Mahdian SMA, Hamblin MR, Tamtaji OR, Afrasiabi A, Jafari A, Mirzaei H. Rajabi A, et al. Mol Ther Oncolytics. 2022 Sep 17;27:100-123. doi: 10.1016/j.omto.2022.09.005. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36321132 Free PMC article. Review.
• A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

  Shelton LM, Mukherjee P, Huysentruyt LC, Urits I, Rosenberg JA, Seyfried TN. Shelton LM, et al. J Neurooncol. 2010 Sep;99(2):165-76. doi: 10.1007/s11060-010-0115-y. Epub 2010 Jan 13. J Neurooncol. 2010. PMID: 20069342
• Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma.

  Andtbacka RHI, Wang Y, Pierce RH, Campbell JS, Yushak M, Milhem M, Ross M, Niland K, Arbeit RD, Parasuraman S, Bickley K, Yeung CC, Aicher LD, Smythe KS, Gan L. Andtbacka RHI, et al. Cancer Res Commun. 2022 Aug 31;2(8):904-913. doi: 10.1158/2767-9764.CRC-22-0090. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923305 Free PMC article. Clinical Trial.